Skip to main content
. Author manuscript; available in PMC: 2014 Sep 4.
Published in final edited form as: J Vet Cardiol. 2011 Oct 24;13(4):231–242. doi: 10.1016/j.jvc.2011.06.001

Table 1.

Mean ± SD hourly heart rate (min−1) in 8 cats after oral administration of placebo and one dose of ivabradine (0.1 mg/kg, 0.3 mg/kg, and 0.5 mg/kg).

Time (h) Placebo Ivabradine (mg/kg)
0.1 0.3 0.5
Baseline 147 ± 21 153 ± 8 154 ± 20 158 ± 12
1 156 ± 27 152 ± 24 149 ± 19a,b 144 ± 23a,b
2 146 ± 19 133 ± 16a 119 ± 18a,b 109 ± 15a,b
3 144 ± 20 133 ± 22 112 ± 20a,b 104 ± 11a,b,c
4 157 ± 24 141 ± 19a 120 ± 13a,b 116 ± 14a,b,c
5 167 ± 29 139 ± 18 128 ± 20 118 ± 14
6 156 ± 30 133 ± 20 128 ± 14 117 ± 11
7 157 ± 29 139 ± 18 131 ± 19 119 ± 15
8 157 ± 26 144 ± 16a 127 ± 23a,b 126 ± 19a,b
9 148 ± 20 150 ± 28 135 ± 11 130 ± 26
10 146 ± 16 144 ± 22 124 ± 11 129 ± 22
11 146 ± 25 138 ± 15 125 ± 15 128 ± 19
12 141 ± 21 135 ± 16 128 ± 18a 124 ± 16a,b
13 143 ± 18 137 ± 17 126 ± 20 133 ± 17
14 145 ± 17 132 ± 14 132 ± 26 137 ± 21
15 143 ± 17 132 ± 16 133 ± 20 132 ± 20
16 149 ± 25 140 ± 22 135 ± 16 138 ± 20
17 149 ± 25 135 ± 12 136 ± 17 140 ± 21
18 142 ± 21 133 ± 15 138 ± 18 141 ± 27
19 139 ± 16 132 ± 14 144 ± 25 143 ± 25
20 141 ± 16 140 ± 25 134 ± 23 149 ± 25
21 141 ± 22 133 ± 11 131 ± 18 132 ± 15
22 142 ± 19 134 ± 11 141 ± 28 126 ± 17
a

Significant differences (P < 0.05) compared to placebo.

b

Significant differences (P < 0.05) compared to ivabradine (0.1 mg/kg).

c

Significant differences (P < 0.05) compared to ivabradine (0.3 mg/kg). Data were compared only at hours 0, 1, 2, 3, 4, 8, and 12.